LATEST
GTCR agreed to acquire CCC Intelligent SolutionsnewEQT agreed to acquire StockbridgenewMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire RocscienceSRS Acquiom / PantaraiSpaceX agreed to acquire nationwide 800 MHz spectrum portfolioAEA Investors acquired RensaWittington Investments agreed to acquire BootsEurazeo / MIYA Water: majority stakeMiddle River Power acquired Panoche Energy Center
Open App
ClosedPublished 6 Aug 2026

Ensysce Biosciences, Inc. /
Cy Biopharma, Inc.

Ensysce Biosciences, Inc. Completes Merger With Cy Biopharma, Inc.

Buy side: Ensysce Biosciences, Inc.
Buy sideEnsysce Biosciences, Inc.
Target: Cy Biopharma, Inc.
TargetCy Biopharma, Inc.
Ensysce Biosciences, Inc. · 6 Aug 2026Source
See the source
Follow Ensysce Biosciences, Inc. Follow Cy Biopharma, Inc.
Buy side: Ensysce Biosciences, Inc.
Buy sideEnsysce Biosciences, Inc.
Target: Cy Biopharma, Inc.
TargetCy Biopharma, Inc.
01 / BuyerEnsysce Biosciences, Inc.
02 / TargetCy Biopharma, Inc.
Source for the buyer and target: Ensysce Biosciences, Inc.

For the buyer and target.

“On August 5, 2026, Ensysce Biosciences, Inc., a Delaware corporation (“we,” “us,” “our,” or the “Company”), acquired Cy Biopharma, Inc., a Delaware corporation (“Cy”), in accordance with the terms of an Agreement and Plan of Merger, dated August 5, 2026 (the “Merger Agreement”), by and among the Company, PHRMA Merger Sub I, Inc., a Delaware corporation (“First Merger Sub”), PHRMA Merger Sub II, LLC, a Delaware limited liability company (“Second Merger Sub”), and Cy.”

Published 6 Aug 2026

Open the source
01

What happened

On Aug. 5, 2026, Ensysce Biosciences, Inc. acquired Cy Biopharma, Inc. through a merger. Cy became a wholly owned subsidiary of Ensysce Biosciences, Inc. [01]

In exchange for Cy’s outstanding capital stock, Ensysce Biosciences, Inc. issued the right to receive 282,122 shares of Series C Preferred Stock. Each share is convertible into 1,000 shares of common stock, subject to certain conditions. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc. Completes Merger With Cy Biopharma, Inc.

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Also stated

    “Ensysce Biosciences, Inc. Completes Merger With Cy Biopharma, Inc. On Aug. 5, 2026, Ensysce Biosciences, Inc. acquired Cy Biopharma, Inc. through a merger”

    Open the source

  2. Published by Ensysce Biosciences, Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.

04

Deal Web

Every firm and person on this deal, and how they connect. Open any name to see their other deals.

Deal Web · 2 firms · 0 peopleHover a name to see how it connects
This dealEnsysce Biosciences, Inc. / Cy Biopharma, Inc.Closed · Published 6 Aug 2026
BuyerEnsysce Biosciences, Inc.TargetCy Biopharma, Inc.
This dealEnsysce Biosciences, Inc. / Cy Biopharma, Inc.

Closed · Ensysce Biosciences, Inc. acquired Cy Biopharma, Inc. (Closed, published 6 Aug 2026).

Published 6 Aug 2026
Timeline
  1. Also stated
  2. Published by Ensysce Biosciences, Inc.
Hover or tap a name to see how it connects, and when
Deal Web as a list